Upcoming Events
  1. Consumer training workshops

    July 17 @ 12:30 pm - 2:00 pm
  2. Conducting systematic reviews: A short course for thoracic oncology nurses

    August 5 @ 6:30 pm
  3. 6th ALTG Lung Cancer Preceptorship

    October 23 @ 10:00 am - October 24 @ 3:30 pm
  4. ALTG open MAC and SAC meetings

    November 20

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

Lung Cancer News

International patient-driven ROS1+ research initiative

The Bonnie J. Adario Lung Cancer Foundation (ALCF) is coordinating an international, patient-driven research project for ROS1+ cancer of all types. An initial survey has been designed in collaboration with experts at Stanford University to collect baseline data for any patients with ROS1+ tumours. This initiative and the ALCF are an excellent mechanism through which patients with this relatively rare type of disease can find support from other patients. Download the flyer for more information. Please circulate this among your networks and keep it in mind for any patients you know with this particular mutation.

Free IASLC membership for patients/survivors

In its July newsletter IASLC announced free membership for patients and survivors of any thoracic malignancy. Patients and survivors can renew this non-voting membership annually. Except for voting, this new membership category provides all Allied Health Professional member benefits and includes online access to the Journal of Thoracic Oncology, member meeting discounts, eligibility to apply for travel awards, and eligibility to serve on Committees.

Molecular testing guideline for EGFR and ALK TKIs – comments open on draft recommendations

The College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC) and Association for Molecular Pathology (AMP) are inviting comment on the draft recommendations for revising the Molecular Testing Guideline for lung cancer patients for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors.  More information is available here.